Why is Glenmark Pharma falling/rising?

As of 14-Jul, Glenmark Pharmaceuticals Ltd. is experiencing a price increase, currently at Rs 2,218.20, reflecting a rise of Rs 36.65 or 1.68%. The stock has shown strong performance recently, gaining 21.82% over the last three days and is currently trading close to its 52-week high, just 3.06% away from Rs 2,286.15. Additionally, the stock has outperformed its sector by 0.78% today and is trading above all key moving averages, indicating a strong upward trend. The company has also demonstrated robust financial health, with a low Debt to EBITDA ratio of 1.00 times and positive results for the last four consecutive quarters, including a remarkable 576.7% growth in PAT for the latest quarter compared to the previous four-quarter average.
In the broader market context, Glenmark's recent performance stands in stark contrast to the benchmark Sensex, which has declined by 1.42% over the past week. Over the past month, Glenmark has achieved a return of 32.75%, while the Sensex has only increased by 1.40%. This significant outperformance over various time frames, including a 60.79% return over the past year, highlights the stock's strong momentum and investor confidence, particularly bolstered by high institutional holdings at 37.8%. The rising investor participation, evidenced by a substantial increase in delivery volume, further supports the stock's upward trajectory.